Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-11

Clinical Trial Update: Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery [NA]

View source ↗

Summary

This clinical trial update discusses a study evaluating desmopressin (DDAVP) combined with tranexamic acid (TXA) to reduce blood loss and transfusion needs duri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DDAVP (desmopressin acetate)
  • TXA (tranexamic acid)

Snippet

Sponsor: Liu Weifeng | Conditions: Idiopathic Scoliosis | NA | Status: UNKNOWN